Look for our booth!
presented by
Dr. Baljit Singh
Chief Executive Officer
INOVIS AG
(formerly Director Insights, Novartis Pharma AG)
details TBA
In a rapidly evolving pharmaceutical landscape shaped by AI, regulatory shifts, and commercialization pressures and VUCA (Volatility, Uncertainty, Complexity, and Ambiguity), the objective of this keynote is to spotlight the strategic edge offered by Primary Competitive Intelligence (CI). This session explores how primary CI—grounded in direct, real-world insight—can inform timely course correction, future-proof decision-making, and sharpen competitive advantage across the product lifecycle from early stage evaluation to late life cycle management.
What’s in it for you? Attendees will gain practical understanding of how to integrate primary CI into strategic execution and how deeper insights and how a four-pronged methodology translates to measurable impact leading to strategic advantage.
presented by
Dr. Harshal Kubavat
Head of Strategic Consulting
INOVIS AG
This workshop session (with breakouts), will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS' in-house proprietary methodologies.
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you're a seasoned CI professional veteran, or newer to the field.